Clinical Trial Update: Everolimus in Treating Patients With Previously Treated Unresectable or Metastatic Esophageal Cancer or Stomach Cancer [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating everolimus in patients with previously treated unresectable or metastatic esophageal or gastric cancer has completed with results poste…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Esophageal Cancer
• Gastric Cancer

Drugs mentioned

• Everolimus (everolimus)

Snippet

Sponsor: Translational Oncology Research International | Conditions: Esophageal Cancer, Gastric Cancer | Phase 2 | Status: COMPLETED | Results posted: 2016-03-29